Skip to main content

Table 4 Impact of dietary oil supplements on serum lipid profile and biomarkers

From: The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population

Arm

CO

BO

FO

Variable

Baseline (SD)

Post-oil (SD)

p-value

Baseline (SD)

Post-oil (SD)

p-value

Baseline (SD)

Post-oil (SD)

p-value

T. Choles

183.0 (10.6)

176.8 (10.0)

0.25

182.0 (7.8)

171.9 (7.2)

0.05

180.6 (8.3)

183.0 (10.1)

0.71

HDL

46.0 (2.6)

46.3 (2.6)

0.73

47.6 (2.5)

48.6 (2.9)

0.29

40.7 (2.8)

43.6 (2.8)

0.01

LDL

102.7 (9.1)

98.4 (8.8)

0.53

106.3 (7.3)

96.8 (6.6)

0.04

102.6 (8.3)

107.9 (9.0)

0.32

TG*

172.9 (25.1)

158.4 (18.8)

0.38

140.2 (10.1)

132.0 (10.8)

0.14

187.2 (22.0)

156.8 (14.7)

0.03

CRP

2.36 (0.57)

3.72 (1.00)

0.41

3.03 (0.85)

3.06 (0.86)

0.99

6.08 (3.19)

3.59 (1.03)

0.19

Leptin*

53.5 (6.8)

44.2 (5.3)

0.38

33.3 (6.2)

33.9 (7.4)

0.82

45.1 (11.0)

40.6 (7.2)

0.37

Insulin

20.2 (3.2)

20.6 (3.3)

0.83

15.4 (2.0)

17.7 (2.6)

0.24

19.1 (4.5)

24.6 (6.8)

0.02

Glucose

130.0 (9.8)

130.7 (11.2)

0.93

128.9 (10.8)

125.9 (7.3)

0.93

133.5 (16.7)

128.7 (11.1)

0.33

HOMA-IR*

5.97 (0.83)

6.39 (1.08)

0.6

4.77 (0.84)

5.76 (1.09)

0.2

8.08 (2.76)

9.19 (3.03)

0.14

HbAlc

7.15 (0.34)

7.07 (0.35)

0.41

6.81 (0.30)

6.90 (0.27)

0.83

7.42 (0.33)

7.20 (0.32)

0.05

  1. *p-values derived from log transformed data.
  2. Data are the mean (SD) at baseline and after oil supplementation (combined 4- and 8-week data). Pre – post changes within a supplementation arm that reached statistical significance are shown by a bolded p-value.